Unlocking Potential and Limits of Kinase Inhibitors: The Highway to Enhanced Cancer Targeted Therapy-Reference-Cited by-同舟云学术

Unlocking Potential and Limits of Kinase Inhibitors: The Highway to Enhanced Cancer Targeted Therapy

Published:2024-05-07 Issue:5 Volume:16 Page:625
ISSN:1999-4923
Container-title:Pharmaceutics
language:en
Short-container-title:Pharmaceutics

Author:

Musumeci Francesca¹^ORCID,Schenone Silvia¹

Affiliation:

1. Department of Pharmacy, University of Genoa, Viale Benedetto XV, 3, 16132 Genoa, Italy

Abstract

Kinases are a family of enzymes comprising over five hundred members, which, when overexpressed or hyperactivated, are implicated in the pathogenesis of numerous hematological and solid cancers [...]

Publisher

MDPI AG

Link

https://www.mdpi.com/1999-4923/16/5/625/pdf

Reference8 articles.

1. Trends in Kinase Drug Discovery: Targets, Indications and Inhibitor Design;Attwood;Nat. Rev. Drug Discov.,2021

2. Properties of FDA-Approved Small Molecule Protein Kinase Inhibitors: A 2024 Update;Roskoski;Pharmacol. Res.,2024

3. New Promise and Opportunities for Allosteric Kinase Inhibitors;Lu;Angew Chem. Int. Ed. Engl.,2020

4. Zhong, L., Li, Y., Xiong, L., Wang, W., Wu, M., Yuan, T., Yang, W., Tian, C., Miao, Z., and Wang, T. (2021). Small Molecules in Targeted Cancer Therapy: Advances, Challenges, and Future Perspectives. Signal Transduct. Target. Ther., 6.

5. Antibody Drug Conjugate: The “Biological Missile” for Targeted Cancer Therapy;Fu;Signal Transduct. Target. Ther.,2022

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Lck Function and Modulation: Immune Cytotoxic Response and Tumor Treatment More Than a Simple Event;Cancers;2024-07-24